Publication | Closed Access

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

Pulmonary TuberculosisTreatment And PreventionMedicineRandomised Clinical TrialWeek Versus RifampicinTuberculosisPharmacotherapyHivPharmacologyHiv-negative Patients